查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
人源化小鼠和大鼠模型的全球市场
市场调查报告书
商品编码
1199207

人源化小鼠和大鼠模型的全球市场

Humanized Mouse and Rat Model
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球人源化小鼠和大鼠模型的市场规模由于COVID-19后商务形势的变化，在2022年估算为1亿2,140万美元，在2022年～2030年间预计将以7.7％的年复合成长率增长，2030年达到2亿1,930万美元。

本报告提供全球人源化小鼠和大鼠模型市场相关调查分析，提供市场趋势与促进因素，地区分析，竞争情形等资讯。

目录

第1章 调查手法

第2章 摘要整理

  • 市场概要
  • 主要企业
  • 市场趋势与推动因素
  • 全球市场预测

第3章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他的欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他的亚太地区
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他的南美
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 其他的中东
  • 非洲

第4章 竞争

简介目录
Product Code: MCP12457

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Humanized Mouse and Rat Model Market to Reach $219.3 Million by 2030

In the changed post COVID-19 business landscape, the global market for Humanized Mouse and Rat Model estimated at US$121.4 Million in the year 2022, is projected to reach a revised size of US$219.3 Million by 2030, growing at aCAGR of 7.7% over the period 2022-2030. Humanized Mouse Models, one of the segments analyzed in the report, is projected to record 7.8% CAGR and reach US$205.7 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Humanized Rat Models segment is readjusted to a revised 6.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $33.1 Million, While China is Forecast to Grow at 11% CAGR

The Humanized Mouse and Rat Model market in the U.S. is estimated at US$33.1 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$47.1 Million by the year 2030 trailing a CAGR of 11% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.4% and 6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6% CAGR.

Select Competitors (Total 44 Featured):

  • Axenis S.A.S.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Genoway S.A.
  • Harbour Antibodies BV
  • Hera BioLabs
  • inGenious Targeting Laboratory, Inc.
  • Taconic Biosciences, Inc.
  • The Jackson Laboratory
  • Trans Genic, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Humanized Mouse & Rat Model - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Humanized Mouse and Rat Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Humanized Mouse Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Humanized Mouse Models by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Humanized Rat Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Humanized Rat Models by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Neuroscience by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Neuroscience by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Hematopoesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Hematopoesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Immunology & Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Immunology & Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Academic & Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Academic & Research Institutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 19: World Humanized Mouse and Rat Model Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 21: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 23: World 8-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Humanized Mouse and Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 25: USA 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 29: USA 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • CANADA
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 31: Canada 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Canada 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • JAPAN
    • Humanized Mouse and Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Japan 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 41: Japan 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • CHINA
    • Humanized Mouse and Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 42: China Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 43: China 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 47: China 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • EUROPE
    • Humanized Mouse and Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 49: Europe 8-Year Perspective for Humanized Mouse and Rat Model by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Europe 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 55: Europe 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • FRANCE
    • Humanized Mouse and Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 57: France 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 59: France 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 61: France 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • GERMANY
    • Humanized Mouse and Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Germany 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Germany 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Germany 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Italy 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Italy 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 73: Italy 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • UNITED KINGDOM
    • Humanized Mouse and Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 75: UK 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 77: UK 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 79: UK 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Spain 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 82: Spain Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Spain 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 84: Spain Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Spain 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Russia 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 88: Russia Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Russia 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 90: Russia Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Russia 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of Europe 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Rest of Europe 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 96: Rest of Europe Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 97: Rest of Europe 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Humanized Mouse and Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific 8-Year Perspective for Humanized Mouse and Rat Model by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2023 & 2030
    • TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 101: Asia-Pacific 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 102: Asia-Pacific Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 103: Asia-Pacific 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • AUSTRALIA
    • Humanized Mouse and Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 106: Australia Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 107: Australia 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 108: Australia Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 109: Australia 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Australia 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • INDIA
    • Humanized Mouse and Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 112: India Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 113: India 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 114: India Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 115: India 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 117: India 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • SOUTH KOREA
    • TABLE 118: South Korea Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 119: South Korea 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 120: South Korea Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 121: South Korea 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 123: South Korea 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 124: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 125: Rest of Asia-Pacific 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 126: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • LATIN AMERICA
    • Humanized Mouse and Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 130: Latin America Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 131: Latin America 8-Year Perspective for Humanized Mouse and Rat Model by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2023 & 2030
    • TABLE 132: Latin America Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 133: Latin America 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Latin America 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 136: Latin America Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 137: Latin America 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • ARGENTINA
    • TABLE 138: Argentina Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 139: Argentina 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Argentina 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 142: Argentina Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 143: Argentina 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • BRAZIL
    • TABLE 144: Brazil Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 145: Brazil 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Brazil 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 148: Brazil Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 149: Brazil 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • MEXICO
    • TABLE 150: Mexico Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 151: Mexico 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Mexico 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 154: Mexico Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 155: Mexico 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 156: Rest of Latin America Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 157: Rest of Latin America 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 160: Rest of Latin America Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 161: Rest of Latin America 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • MIDDLE EAST
    • Humanized Mouse and Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 162: Middle East Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 163: Middle East 8-Year Perspective for Humanized Mouse and Rat Model by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2023 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Middle East 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 166: Middle East Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 167: Middle East 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 168: Middle East Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 169: Middle East 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Iran 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 172: Iran Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 173: Iran 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 174: Iran Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 175: Iran 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Israel 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 178: Israel Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 179: Israel 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 180: Israel Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 181: Israel 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 184: Saudi Arabia Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 185: Saudi Arabia 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 186: Saudi Arabia Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 187: Saudi Arabia 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 189: UAE 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 190: UAE Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 191: UAE 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 192: UAE Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 193: UAE 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 196: Rest of Middle East Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 197: Rest of Middle East 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 198: Rest of Middle East Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 199: Rest of Middle East 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030
  • AFRICA
    • Humanized Mouse and Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Type - Humanized Mouse Models and Humanized Rat Models - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Africa 8-Year Perspective for Humanized Mouse and Rat Model by Type - Percentage Breakdown of Value Sales for Humanized Mouse Models and Humanized Rat Models for the Years 2023 & 2030
    • TABLE 202: Africa Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by Application - Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 203: Africa 8-Year Perspective for Humanized Mouse and Rat Model by Application - Percentage Breakdown of Value Sales for Oncology, Immunology & Infectious Diseases, Neuroscience, Hematopoesis and Other Applications for the Years 2023 & 2030
    • TABLE 204: Africa Recent Past, Current & Future Analysis for Humanized Mouse and Rat Model by End-Use - Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 205: Africa 8-Year Perspective for Humanized Mouse and Rat Model by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions, Pharma & Biotech Companies and Contract Research Organizations (CROs) for the Years 2023 & 2030

IV. COMPETITION